as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
1.35%
Downside
4.84%
Upside
52 Week's Low
52 Week's High
83.88%
Downside
7.35%
Upside
Check Pyxis Oncology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$323.2M
EPS (TTM)
-1.295
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-80.5M
Revenue (TTM)
2.8M
Profit Margin
0.00%
Return On Equity TTM
-87.28%
Compare market cap, revenue, PE, and other key metrics of Pyxis Oncology, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $323.2M | NA | NA | 0.00% | |
| BUY | $44.3B | 430.84% | -16.34 | -264.83% | |
| BUY | $59.6B | 241.14% | 1410.09 | 1.36% | |
| BUY | $111.2B | 88.28% | 30.49 | 31.35% | |
| BUY | $82.7B | 51.77% | 18.69 | 32.13% |
The Pyxis Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pyxis Oncology, Inc. investment value today
Current value as on today
₹2,62,620
Returns
₹1,62,620
(+162.62%)
Returns from Pyxis Oncology, Inc. Stock
₹1,57,214 (+157.21%)
Dollar Returns*
₹5,406 (+5.41%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Pyxis Oncology, Inc.. Average target price of $7.67
Get share price movements and forecasts by analysts on Pyxis Oncology, Inc..
What analysts predicted
32.59%UPSIDE
Target Price
$7.67
Current Price
$5.17
Analyzed by
13 Analysts
Target
$7.67
Pyxis Oncology, Inc. target price $7.67, a slight upside of 32.59% compared to current price of $5.17. According to 13 analysts rating.
Search interest for Pyxis Oncology, Inc. Stock has increased by 107% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:107% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, PYXS stock has moved up by 305.5%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 18.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 986.7% return, outperforming this stock by 728.8%
| Organisation | Pyxis Oncology, Inc. |
| Headquarters | 321 Harrison Avenue, Boston, MA, United States, 02118 |
| Industry | Services |
| CEO | Dr. Lara S. Sullivan M.D., MBA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Lara S. Sullivan M.D., MBA | CEO, President, Chief Medical Officer & Director |
Dr. Jan Pinkas Ph.D. | Chief Scientific Officer |
Donna Regalado | Head of Human Resources |
Dr. Charles T. Gombar Ph.D. | Senior Vice President of Portfolio & Program Management |
Dr. Michael Bui | Head of Global Regulatory Affairs |
Mr. Jitendra Wadhane C.A., CPA | Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer |
Dr. Balu N. Balasubramanian Ph.D. | Interim Chief Technology Officer |
Mr. Alex Kane M.B.A. | Senior Vice President of Investor Relations & Capital Markets |
Mr. Stephen T. Worsley MBA | Senior VP & Chief Business Officer |
Dr. Supriya Roth Ph.D. | Head of Commercial Development |
Pyxis Oncology, Inc. share price today is $5.17 as on at the close of the market. Pyxis Oncology, Inc. share today touched a day high of $5.42 and a low of $5.1.
Pyxis Oncology, Inc. share touched a 52 week high of $5.55 on and a 52 week low of $0.83 on . Pyxis Oncology, Inc. stock price today i.e. is closed at $5.17,which is 6.85% down from its 52 week high and 520.50% up from its 52 week low.
Pyxis Oncology, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Pyxis Oncology, Inc. (PYXS) shares with as little as ₹89.332 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.32 in Pyxis Oncology, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pyxis Oncology, Inc. share’s latest price of $5.17 as on November 28, 2025 at 11:29 pm IST, you will get 1.9342 shares of Pyxis Oncology, Inc.. Learn more about
fractional shares .